Advisory Board and Editors Drugs & Devices
Łukasz Jaremko
Dr. Łukasz Jaremko is Associate Professor at King Abdullah University of Science and Technology.
Research in Dr. Jaremko's Molecular Diagnostics and Drug Discovery (MD3) group focuses on atomic-level insight into essential and topical questions from biochemistry and medicine.
Alex Kentsis
Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University.
He leads research in the functional proteomics and genomic plasticity of refractory childhood cancers.
Maria Paula M Marques
Maria Paula Marques (October 1960, Portugal) received her MSc in Physical-Chemistry (1987), her PhD (1995) and her habillitation (2018) from the University of Coimbra (Portugal). M.P.M. Marques is currently an assistant professor at the Department of Life Sciences of the University of Coimbra, assistant-coordinator of the R&D Group “Molecular Physical-Chemistry” and head of the “Chemoprevention, -Therapy & -Toxicology” laboratory. M.P.M. Marques has authored 140 scientific papers, 8 book chapters and co-edited 3 books. She is a fellow of the Royal Society of Chemistry and a member of the Clinical Infrared and Raman Spectroscopy for Medical Diagnosis (CLIRSPEC), the portuguese delegate for the COST Action Raman4Clinics, an associate editor of RSC Advances and a member of the editorial board of Recent Patents on Anti-Cancer Drug Discovery.
Her research is centred on the development of metal-based antitumour agents and on the early diagnostics of cancer, using vibrational spectroscopy, including neutron techniques and synchrotron-based methods.
KoonGee Neoh
Professor of Chemical Engineering at the National University of Singapore. Recipient of the 1996 National Science Award of Singapore.
Marisa Fabiana Nicolás
Dr. Marisa Fabiana Nicolás is a biologist with a Ph.D. in Genetics. She worked as a protein annotator in the UniProt/Swiss-Prot database from 2005 to 2007. Since May 2009 she is an Associate Researcher at the Bioinformatics Laboratory (Labinfo) at LNCC/MCTI Brazil. Dr. Nicolas has experience in Genetics, Molecular Biology, Genomics, and Bioinformatics. She works mainly in Bioinformatics applied to the analysis of genomes and transcriptomes (RNAseq and scRNAseq) and metabolic and regulatory networks in clinically relevant pathogens.
Audrey R Odom John
Chief, Division of Infectious Diseases, Children's Hospital of Philadelphia
The primary research goals of our lab are to understand the biological functions of specific metabolic pathways in the malaria parasite--that is, to understand what the parasite needs to make, and why it needs to make it.
Sonia MR Oliveira
Doctor Sonia Oliveira holds a Licenciatura in Biology (pre-Bologna) and a Master in Cellular and Molecular Biology from the University of Aveiro, where she also specialized in medicinal plants, toxicology, murine models, and spermatogenesis. In 2011 she moved to Australia to work in Reproductive Biological Sciences. She later explored the nerve-cancer connection in Cancer, namely in female cancers, and completed her Ph.D. in Human Physiology ( with a significant component in Medical Biochemistry and Neurophysiology) from the University of Newcastle (Australia) in 2018. She then worked with biomimetic systems and nanotechnology in diabetes and stem cells. She explored multiple methods for primary and secondary cell culture, always with a keen interest in histopathology, cell biology, and rare disorders. Participated in >40 event(s). (Co-)Supervised MSc dissertation(s) and final projects for course completion of LSc/BSc. And works mostly in the area(s) of Natural sciences with emphasis on Molecular and Cellular Biology, and Medical and Health Sciences with emphasis on Neurosciences, Cancer, Reproduction, Toxicology, Biotechnology, and Stem cells. Also has collaborations in Microbiology, Biomaterials, and Communication and Information technologies.
Adegboyega K Oyelere
Educational Background: B.Sc. Chemistry (Industrial Option), 1st Class Honors, 1992, University of Ibadan, Nigeria. Ph.D. Organic Chemistry, 1998, Brown University, Providence Rhode Island
Employment History:
July 1998 – Nov. 2001: Postdoctoral Associate and Jane Coffin Childs Postdoctoral Fellow, Dept. of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut.
Nov. 2001 – Jan. 2004: Research Scientist II, Rib-X Pharmaceuticals, Inc.
Jan. 2004 – Aug. 2005: Senior Research Scientist, Rib-X Pharmaceuticals, Inc.
Aug. 2005 – April 2011: Assistant Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
Dec. 2007 – Nov. 2009: Blanchard Assistant Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
April 2011 – March 2022: Associate Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
March 2022 – Present: Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
Maura Pellei
Maura Pellei is Associate Professor of General and Inorganic Chemistry at the University of Camerino. In 1993 she graduated in biological science at the University of l′Aquila. She obtained her degree in chemistry in 2003 and her Ph.D. in chemical sciences in 2010 at the University of Camerino. Her research interests are in coordination
chemistry, bioinorganic systems, and metal-based drugs.
Jiangjiang Qin
Dr. Jiangjiang Qin is currently a Professor of Cancer Pharmacology and Drug Discovery at the Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences and the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital).
Dr. Qin received his B.S. degree in Pharmacy (2006) and Ph.D. in Biomedical Engineering with the highest honor (2011) from Shanghai Jiao Tong University, China, under the supervision of Professor Wei-Dong Zhang. After completion of Post-Doctoral training in cancer biology, pharmacology, and molecular therapeutics at Texas Tech University Health Sciences Center (TTUHSC) in 2014, Dr. Qin continued his research work at TTUHSC as a Research Associate and a Senior Research Associate and at the University of Houston as a Senior Research Scientist. Dr. Qin joined Zhejiang Chinese Medicinal University as a Full Professor in 2018 and then moved to IBMC in 2020.
Dr. Qin’s research mainly focuses on the discovery and development of novel, effective, and safe anticancer agents as well as demonstrating the molecular targets and mechanisms of action. He has published more than 150 research papers and reviews. He is also an Associate Editor of Frontiers in Pharmacology and Frontiers in Oncology and an Editorial Board Member of more than 10 scientific journals such as Recent Patents on Anti-Cancer Drug Discovery, Journal of Cancer Research Updates, World Journal of Traditional Chinese Medicine.
Maria Valeria Raimondi
Prof. Dr. Maria Valeria Raimondi, PhD is Assistant Professor in Medicinal Chemistry, University of Palermo, Italy.
In 2018 and 2020, Dr. Raimondi's was a visiting Scientist in Medicinal Chemistry at the University of Vienna and the University of Hamburg respectively. Prior to this Dr. Raimondi was Assistant Professor in Medicinal Chemistry at the University of Palermo
Her scientific interests include:
-Synthesis and antimicrobial evaluation of new compounds with phenoxyacetamidic and iodobenzamidic structure
-Synthesis and antiproliferative activity of new derivatives with triazenic, tetrazepinonic and indazolocarboxyamidic structure
-Design and synthesis of new derivatives with a 4-quinazolinone structure, potential inhibitors of folate receptors
-Synthesis of new pyrrole derivatives related to pyrrolomycin inhibitors of Sortase A
-Synthesis of pyrazole and indazole derivatives, potential inhibitors of CDK1
-Identification of new sigma receptor ligands. Design and synthesis of a beta-aminoketones drug discovery library
-Microwave-assisted organic synthesis (MAOS) of compounds with potential antitumor activity
-Synthesis of polycyclic structures with marked antitumor activity in vitro
-Qualitative and quantitative analysis of industrial hydrocolls from the citrus industries
http://orcid.org/0000-0003-3143-738X
Scopus Author ID: 7006063479
David Rodríguez-Sanz
Dr. David Rodríguez-Sanz is a professor at the Universidad Complutense de Madrid, Spain.
His main research interest is focused in the field of foot and ankle, muscle, tendon, biomechanics, sports.